Showing results (341-350 of 372) with videos related to

Sort By:
Pageof 38
Pediatric Blood & Cancer|June 20, 2023
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenograftsKeira Hughes, Kathryn Evans, Eric J Earley, et al.
International Journal of Oncology|May 4, 2011
Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modelingCecile Rouleau, Robert Smale, Yao-Shi Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorptionEnrique Alvarez, Michael Westmore, Rachelle J Sells Galvin, et al.
Cancer Research Communications|November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastomaKateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
International Journal of Oncology|June 25, 2011
Endosialin: a novel malignant cell therapeutic target for neuroblastomaCecile Rouleau, Robert Smale, Jose Sancho, et al.
Pediatric Blood & Cancer|May 7, 2011
Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing programPeter J Houghton, Richard Lock, Hernan Carol, et al.
Pageof 38